SCHEMBL29596286

SCHEMBL29596286

N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MME P08473 4/20 0.58
LTA4H P09960 1/20 0.55
NAALAD2 Q9Y3Q0 1/20 0.55
SLC15A1 P46059 1/20 0.54
CTSC P53634 1/20 0.53
ALPI P09923 1/20 0.53
PKM P14618 1/20 0.53
PTGS1 P23219 1/20 0.53
XIAP P98170 1/20 0.53
SLC7A5 Q01650 1/20 0.53
ACE P12821 2/20 0.52
CPA1 P15085 2/20 0.52
ACE2 Q9BYF1 2/20 0.52
GNPAT O15228 1/20 0.52
BACE1 P56817 1/20 0.51
BACE2 Q9Y5Z0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29430082 0.96 MME (0.60) MMELTA4HNAALAD2SLC15A1CTSC
SCHEMBL30797900 0.96 MME (0.63) MMELTA4HNAALAD2SLC15A1CTSC
SCHEMBL29834943 0.94 MME (0.58) MMELTA4HNAALAD2SLC15A1ACE
SCHEMBL8630193 0.94 MME (0.58) MMELTA4HNAALAD2SLC15A1ACE
SCHEMBL29669678 0.94 MME (0.61) MMELTA4HSLC15A1CTSCALPI
SCHEMBL30917975 0.94 MME (0.52) MMELTA4HNAALAD2SLC15A1CTSC
SCHEMBL29608649 0.94 MME (0.59) MMEACE
SCHEMBL2878352 0.93 MME (0.66) MMELTA4HSLC15A1CTSCALPI
SCHEMBL29498365 0.93 MME (0.66) MMELTA4HSLC15A1CTSCALPI
SCHEMBL4778524 0.93 MME (0.66) MMELTA4HSLC15A1CTSCALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271398-A Preparation and application of hypoglycemic peptide 重庆三峡学院 2024-07-02 CN claimed
US-20240165006-A1 DERMATOLOGICAL COMPOSTIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2024-05-23 US claimed
EP-4313105-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF Bone Sci. Bio Ltd. (IL) 2024-02-07 EP claimed
US-20230130132-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF BONE SCI. BIO LTD. (IL) 2023-04-27 US claimed
EP-4125993-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF Bone Sci. Bio Ltd. (IL) 2023-02-08 EP claimed
WO-2022201146-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2022-09-29 WO claimed
CN-114437207-A Humanized anti-Hantavirus (HTNV) Fab antibody with neutralization activity and application 中国人民解放军空军军医大学 2022-05-06 CN claimed
CN-118271398-A Preparation and application of hypoglycemic peptide 重庆三峡学院 2024-07-02 CN disclosed
CN-118271398-A Preparation and application of hypoglycemic peptide 重庆三峡学院 2024-07-02 CN disclosed
US-20240165006-A1 DERMATOLOGICAL COMPOSTIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2024-05-23 US disclosed
EP-4313105-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF Bone Sci. Bio Ltd. (IL) 2024-02-07 EP disclosed
US-20230130132-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF BONE SCI. BIO LTD. (IL) 2023-04-27 US disclosed
EP-4125993-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF Bone Sci. Bio Ltd. (IL) 2023-02-08 EP disclosed
WO-2022201146-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2022-09-29 WO disclosed